24小时热门版块排行榜    

查看: 3021  |  回复: 14
当前只显示满足指定条件的回帖,点击这里查看本话题的所有回帖

letdd

新虫 (初入文坛)

[交流] JPBA 投稿被拒,贴出拒稿信,求指点已有5人参与

Dear Dr. Zhu,

I regret to inform you that, after consideration of our reviewers' comments on your paper (with which I fully agree), I'm unable to accept it for publication.

For your guidance, I append the reviewers' comments below.

Please note that a great many more papers are submitted to JPBA than we can possibly publish. The acceptance rate for papers is about 25% and our decision is not a reflection of the quality of your research but rather of our stringent requirements.

The Editors hope that you do understand the above decision, and we appreciate your continued interest in the Journal of Pharmaceutical and Biomedical Analysis.

Thank you for giving us the opportunity to consider your work. We wish you every success when you submit the paper elsewhere.

Yours sincerely,

Sándor Görög
Editor
Journal of Pharmaceutical and Biomedical Analysis

Reviewers' comments:


Reviewer #1: This paper is about Identification of major compounds in rat bile, plasma and urine after oral administration of Radix Scutellariae extract by ultra-fast liquid chromatography coupled to ion trap time-of-flight mass spectrometry.
Although these observation are interesting, they are rather limited and do not advance our knowledge of the subject sufficiently to warrant publication in JPBA.
1.        It is noted that your manuscript needs careful editing by someone with expertise in technical English editing paying particular attention to English grammar, spelling, and sentence structure.
2.        The innovation of this manuscript is weak and the content of experiments is not plentiful.
3.        The Fig.4 and Fig.4 are not clearly expressed, and the Fig.5 should be deleted. It will be nice if you can add the schematic diagram of the cracking.
Based on what was described above this manuscript is not suitable for publication in the journal of JPBA. We suggest that the authors try submitting their findings to other journals.




Reviewer #2: I do not recommend the publication of this manuscript due mainly to the lack of scientific novelty and for neglecting the comparison of the authors' method and results with those in the literature. The Guide for Authors of JPBA contains the following restriction: "In determining the suitability of submitted articles for publication, particular scrutiny will be placed on the degree of novelty and significance of the research and the extent to which it adds to existing knowledge in pharmaceutical and biomedical analysis. In all submissions to the journal, authors must address the question of how their proposed methodology compares with previously reported methods."
The authors have missed to make reference to closely related papers such as
Ling Tong, Meixu Wan, Lihua Zhang, Yonghong Zhu, He Sun, Kaishun Bi,  Simultaneous determination of baicalin, wogonoside, baicalein, wogonin, oroxylin A and chrysin of Radix scutellariae extract in rat plasma by liquid chromatography tandem mass spectrometry, Journal of Pharmaceutical and Biomedical Analysis (2012) (from the same university!!!) and
Chung, H.J., Lim, S., Kim, I.S., Bu, Y., Kim, H., Kim, D.-H., Yoo, H.H., Simultaneous determination of baicalein, baicalin, wogonin, and wogonoside in rat plasma by LC-MS/MS for studying the pharmacokinetics of the standardized extract of scutellariae radix, Bulletin of the Korean Chemical Society,  33 (2012) 177-182.
Reference has been made to [23] but real comparison was not made.
回复此楼
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

liuqingwang

金虫 (小有名气)


小木虫: 金币+0.5, 给个红包,谢谢回帖
引用回帖:
10楼: Originally posted by 小兵虾米 at 2013-08-05 11:25:55
阁下的JPBA文章最后接受了没呢?一审用了多久啊...

一审也就一个月左右,最后被拒了,理由是创新性不强,我同意他的观点。。。
11楼2013-08-05 14:43:54
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
查看全部 15 个回答

独步青云

新虫 (职业作家)

术中小生


小木虫: 金币+0.5, 给个红包,谢谢回帖
我仔细看了审稿意见。
首先不要再投JPBA了,通过几点老鼠,利用LC/MS进行简单地鉴定入血成分,自去年JPBA就不收了。随着IF的增长,其在代谢方面要求显著提高。
审稿人认为你的方法没有什么特色,换句话说你的发现没有什么闪光点。另外一定得和已报道文献进行比对,说明你方法的先进性。任何文章只报道自己东西,没有和先前文献对比的话,肯定是一短板。尤其遇到做过相关研究的审稿人,他认变你没有好好看文献。
2楼2012-09-02 12:46:48
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

letdd

新虫 (初入文坛)

引用回帖:
2楼: Originally posted by 独步青云 at 2012-09-02 12:46:48
我仔细看了审稿意见。
首先不要再投JPBA了,通过几点老鼠,利用LC/MS进行简单地鉴定入血成分,自去年JPBA就不收了。随着IF的增长,其在代谢方面要求显著提高。
审稿人认为你的方法没有什么特色,换句话说你的发现 ...

可能标题有误导,我做的代谢产物结构鉴定的。鉴定了20种代谢产物。和10种入血成分。
3楼2012-09-06 13:26:40
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

独步青云

新虫 (职业作家)

术中小生


小木虫: 金币+0.5, 给个红包,谢谢回帖
引用回帖:
3楼: Originally posted by letdd at 2012-09-06 13:26:40
可能标题有误导,我做的代谢产物结构鉴定的。鉴定了20种代谢产物。和10种入血成分。...

我没有被误解。像黄芩做这以多,你鉴定的结果也没有多大的突破。如果我是审稿人也会拒这方面的文章。是文章的要求高了,没有办法。换在两年前还是可以的。
4楼2012-09-06 15:04:30
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
普通表情 高级回复(可上传附件)
信息提示
请填处理意见